Showing 881 - 900 results of 3,158 for search 'Patient Number 9', query time: 0.10s Refine Results
  1. 881
  2. 882

    The Effect of Calcitonin Gene-Related Peptide Monoclonal Antibodies on Quality of Life among Migraine Patients: Pilot Study at the Hospital of Lithuanian University of Health Scien... by Monika Remenčiūtė, Greta Varžaitytė, Gintarė Žemgulytė

    Published 2024-05-01
    “…Three months after treatment, CM changed to EM for 19 patients (79.2%), 27 patients (65.9%) had ≥50% reduction in the number of MMD and total migraine disability assessment (MIDAS) score was reduced by >50% in 31 patients (75.6%). …”
    Get full text
    Article
  3. 883
  4. 884
  5. 885
  6. 886

    Indocyanine Green Fluorescence Plus Blue Dye for Sentinel Lymph Node Biopsy in Patients Undergoing Neoadjuvant Chemotherapy for Breast Cancer: A Multicenter, Prospective Cohort Stu... by Miao Liu, Yang Yang, Bin Hua, Rui Feng, Tianyu Xu, Mengyuan Wang, Xiaowei Qi, Yingming Cao, Bo Zhou, Fuzhong Tong, Peng Liu, Hongjun Liu, Lin Cheng, Houpu Yang, Fei Xie, Siyuan Wang, Chaobin Wang, Yuan Peng, Danhua Shen, Lei Chen, Jun Jiang, Shu Wang

    Published 2025-01-01
    “…ABSTRACT Background Sentinel lymph node biopsy (SLNB) using radioisotope tracer plus blue dye is the gold standard after neoadjuvant chemotherapy (NAC) in initially cN1 breast cancer patients, but clinical use still has limitations. This study aims to examine diagnostic performance of dual indocyanine green (ICG) and methylene blue tracing for SLNB in patients who have completed NAC for breast cancer with initially cN1 disease. …”
    Get full text
    Article
  7. 887
  8. 888
  9. 889
  10. 890
  11. 891

    A modified screening protocol for ARDS in patients with respiratory support based on SpO2 and FiO2: A single-center prospective, observational study by Yan Xia, Qiancheng Xu, Zhiyuan Guo, Huijuan Zhang, Yingya Cao, Yupeng Qi, Qun Chen, Weihua Lu

    Published 2025-01-01
    “…The demographic and clinical data, immediate percutaneous SpO2, FiO2, arterial oxygen partial pressure (PaO2), and respiratory rate were recorded; and the SpO2/FiO2 ratio (SFR) and PaO2/FiO2 ratio (PFR) values were calculated according to the above information. The patients were divided into two cohorts by random number table: the establishment cohort and the verification cohort. …”
    Get full text
    Article
  12. 892
  13. 893
  14. 894
  15. 895
  16. 896
  17. 897
  18. 898
  19. 899

    Does providing atrial fibrillation patients, after pulmonary vein isolation, with a 1-lead ECG device relieve the emergency department?-A historically controlled prospective trial. by Jasper L Selder, Mark J Mulder, Willem R van de Vijver, Philip M Croon, Leontine E Wentrup, Stéphanie L van der Pas, Jos W R Twisk, Igor I Tulevski, Albert C Van Rossum, Cornelis P Allaart

    Published 2024-12-01
    “…However, the 1-lead ECG group demonstrated a higher proportion of planned cardioversions compared to unplanned ones (odds ratio 4.9 [1.57-15.85], p = 0.007).<h4>Conclusion</h4>Providing patients with AF following PVI with a 1-lead ECG device did not result in a statistically significant reduction in ED visits during the first year. …”
    Get full text
    Article
  20. 900

    Study of comorbidities in chronic obstructive pulmonary disease patients at tertiary health care centre in south Gujarat just in the era of Covid-19 pandemic − a cross-sectional st... by Sreerag Varior, Parul Vadgama, Robinkumar Patel, Bhoomika Patel, Jignesh Gengadiya

    Published 2023-12-01
    “…The prevalence of ischemic heart disease (8.5%), depression (16.5%), anemia (16%), osteoarthritis (13%), and chronic kidney disease (9.5%) were other comorbidities among the patients. …”
    Get full text
    Article